At a glance
ClinicalIndex Comparison RecordN/ACompleted· 190 enrolled
Drug / intervention
aspirindrug
Likely dose
aspirin 81mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Genotypic and Phenotypic Correlates of Resistance to Anti-platelet Actions of Aspirin in an At-risk Patient Population and in the General Population
In Brief
A clinical study evaluating aspirin for Platelet Dysfunction Due to Aspirin. Completed, enrolled 190 participants across 1 site.
Detailed Summary
The study seeks to identify genomic markers associated with aspirin resistance.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlatelet Dysfunction Due to Aspirin
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2007
Primary CompletionApr 2011
First PostedMay 2011
TodayJul 2026
First PostedMay 27, 2011
Enrollment StartDec 1, 2007
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 15.1 years ago
Interventions
aspirindrug
aspirin 81mg, 7-10 days